Cite

HARVARD Citation

    Lozano, E. et al. (2019). Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy. Hepatology. 70 (4), pp. 1246-1261. [Online]. 
  
Back to record